Showing 1 to 1 of 1 results
arabic.euronews.com
🌐 75% Global Worthiness


Eight-Year Gantenerumab Treatment Shows Promise in Delaying Alzheimer's Onset
A small clinical trial of 22 genetically predisposed individuals showed that eight years of treatment with gantenerumab reduced their risk of developing Alzheimer's symptoms by half; however, the drug was later discontinued due to inefficacy in larger trials.
Eight-Year Gantenerumab Treatment Shows Promise in Delaying Alzheimer's Onset
A small clinical trial of 22 genetically predisposed individuals showed that eight years of treatment with gantenerumab reduced their risk of developing Alzheimer's symptoms by half; however, the drug was later discontinued due to inefficacy in larger trials.
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results